Imberti, Jacopo Francesco
 Distribuzione geografica
Continente #
AS - Asia 4.311
NA - Nord America 4.219
EU - Europa 1.995
SA - Sud America 757
OC - Oceania 250
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.606
Nazione #
US - Stati Uniti d'America 4.110
CN - Cina 1.686
SG - Singapore 1.227
BR - Brasile 635
HK - Hong Kong 631
IT - Italia 622
GB - Regno Unito 327
AU - Australia 248
VN - Vietnam 246
SE - Svezia 225
DE - Germania 219
KR - Corea 186
RU - Federazione Russa 183
FI - Finlandia 87
ID - Indonesia 85
AR - Argentina 57
FR - Francia 55
MX - Messico 47
NL - Olanda 47
CA - Canada 46
IN - India 42
AT - Austria 33
BD - Bangladesh 30
BG - Bulgaria 30
TR - Turchia 29
ZA - Sudafrica 29
LT - Lituania 27
PL - Polonia 25
IQ - Iraq 23
JP - Giappone 21
ES - Italia 17
EC - Ecuador 16
UA - Ucraina 15
AE - Emirati Arabi Uniti 12
CO - Colombia 12
EG - Egitto 12
PK - Pakistan 12
IE - Irlanda 11
KE - Kenya 10
RS - Serbia 10
VE - Venezuela 10
BE - Belgio 9
MA - Marocco 9
PY - Paraguay 9
RO - Romania 9
TH - Thailandia 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
HU - Ungheria 7
MY - Malesia 6
PE - Perù 6
SA - Arabia Saudita 6
TW - Taiwan 6
CL - Cile 5
CU - Cuba 5
DZ - Algeria 5
IR - Iran 5
JO - Giordania 5
KZ - Kazakistan 5
CH - Svizzera 4
GE - Georgia 4
IL - Israele 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
LU - Lussemburgo 3
PT - Portogallo 3
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NI - Nicaragua 1
PA - Panama 1
SY - Repubblica araba siriana 1
Totale 11.604
Città #
Hefei 930
Santa Clara 918
Singapore 796
Hong Kong 630
Ashburn 516
Fairfield 236
Chandler 220
London 205
Beijing 187
Seoul 186
Nyköping 180
Perth 167
New York 143
Los Angeles 118
Ho Chi Minh City 95
Woodbridge 95
Houston 92
Munich 90
Chicago 86
Dallas 82
Seattle 79
The Dalles 78
Wilmington 77
Cambridge 71
Bologna 67
Jakarta 65
São Paulo 63
Shanghai 61
Milan 58
Kent 52
Buffalo 51
Moscow 49
Hanoi 47
San Diego 47
Helsinki 41
Rome 40
Modena 38
Sydney 38
Princeton 37
Ann Arbor 34
Mexico City 30
Sofia 29
Lappeenranta 27
Salt Lake City 27
Southend 25
Redondo Beach 23
Nuremberg 20
Amsterdam 19
Atlanta 19
Johannesburg 19
Tokyo 19
Turku 19
Parma 18
Vienna 18
Düsseldorf 17
Frankfurt am Main 17
Guangzhou 17
Orem 17
Toronto 17
Turin 17
Warsaw 17
Portsmouth 16
Kilburn 15
Stockholm 15
Campinas 14
Rio de Janeiro 14
Belo Horizonte 13
Columbus 13
Haiphong 13
Porto Alegre 13
Brooklyn 12
Denver 12
Elk Grove Village 12
Melbourne 12
Poplar 12
Boston 11
Brasília 11
Dublin 11
Montreal 11
Phoenix 11
Tampa 11
Ankara 10
Biên Hòa 10
Boardman 10
Curitiba 10
Lauterbourg 10
Naples 10
Reggio Emilia 10
Baghdad 9
Da Nang 9
Perugia 9
Ribeirão Preto 9
Baku 8
Belgrade 8
Brussels 8
Carpi 8
Des Moines 8
Jacksonville 8
Miami 8
Salvador 8
Totale 7.918
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 437
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 266
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 236
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 216
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 194
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 174
Remote monitoring and telemedicine in heart failure: implementation and benefits 173
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 169
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 165
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 165
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 163
What do we do about atrial high rate episodes? 160
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 159
Female sex and stroke in atrial fibrillation: an intriguing relationship 158
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 155
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 147
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 137
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 136
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 135
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 133
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 133
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 133
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 131
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 130
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 129
Atrial fibrillation in pneumonia: what clinical implications at long-term? 127
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 124
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 123
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 123
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 122
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 122
Atrial fibrillation burden: Stepping beyond the categorical characterization 121
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 121
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 121
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 121
Single-lead VDD pacing: a literature review on short-term and long-term performance 120
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 117
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 114
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 114
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 114
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 113
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 112
Clinical decisions for appropriate management of patients with atrial fibrillation 111
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 110
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 109
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 106
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 105
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 103
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 101
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 100
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 100
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 99
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 99
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 99
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 98
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 95
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 95
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 95
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 94
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 93
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 93
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 93
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 93
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 91
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 90
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 90
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 86
Antiarrhythmic drugs in the era of atrial fibrillation ablation 86
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 86
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 85
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 85
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 82
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 81
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 79
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 79
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 78
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 76
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 75
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 75
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 73
Progression of Atrial Fibrillation after Cryoablation 73
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 73
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 73
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 72
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 71
Mobile health technology in atrial fibrillation 71
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 69
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 69
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 68
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 68
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 67
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 64
New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development 64
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 63
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 63
Atrial fibrillation screening: The importance of the patient perspective 62
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 62
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 58
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 53
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 51
Totale 11.165
Categoria #
all - tutte 62.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021414 0 0 0 0 0 12 188 85 36 42 24 27
2021/2022667 52 76 14 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20264.226 679 430 805 1.133 995 184 0 0 0 0 0 0
Totale 11.761